BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 24557920)

  • 1. Gene correction of induced pluripotent stem cells derived from a murine model of X-linked chronic granulomatous disorder.
    Mukherjee S; Thrasher AJ
    Methods Mol Biol; 2014; 1114():427-40. PubMed ID: 24557920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lentivirus-mediated gene transfer of gp91phox corrects chronic granulomatous disease (CGD) phenotype in human X-CGD cells.
    Saulnier SO; Steinhoff D; Dinauer MC; Zufferey R; Trono D; Seger RA; Hossle JP
    J Gene Med; 2000; 2(5):317-25. PubMed ID: 11045425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of functional neutrophils from a mouse model of X-linked chronic granulomatous disorder using induced pluripotent stem cells.
    Mukherjee S; Santilli G; Blundell MP; Navarro S; Bueren JA; Thrasher AJ
    PLoS One; 2011 Mar; 6(3):e17565. PubMed ID: 21408614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TALEN-mediated functional correction of X-linked chronic granulomatous disease in patient-derived induced pluripotent stem cells.
    Dreyer AK; Hoffmann D; Lachmann N; Ackermann M; Steinemann D; Timm B; Siler U; Reichenbach J; Grez M; Moritz T; Schambach A; Cathomen T
    Biomaterials; 2015 Nov; 69():191-200. PubMed ID: 26295532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional Restoration of gp91phox-Oxidase Activity by BAC Transgenesis and Gene Targeting in X-linked Chronic Granulomatous Disease iPSCs.
    Laugsch M; Rostovskaya M; Velychko S; Richter C; Zimmer A; Klink B; Schröck E; Haase M; Neumann K; Thieme S; Roesler J; Brenner S; Anastassiadis K
    Mol Ther; 2016 Apr; 24(4):812-22. PubMed ID: 26316390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical correction of X-CGD by a novel chimeric promoter regulating high levels of transgene expression in myeloid cells.
    Santilli G; Almarza E; Brendel C; Choi U; Beilin C; Blundell MP; Haria S; Parsley KL; Kinnon C; Malech HL; Bueren JA; Grez M; Thrasher AJ
    Mol Ther; 2011 Jan; 19(1):122-32. PubMed ID: 20978475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene therapy for chronic granulomatous disease.
    Kang EM; Malech HL
    Methods Enzymol; 2012; 507():125-54. PubMed ID: 22365772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transgene optimization significantly improves SIN vector titers, gp91phox expression and reconstitution of superoxide production in X-CGD cells.
    Moreno-Carranza B; Gentsch M; Stein S; Schambach A; Santilli G; Rudolf E; Ryser MF; Haria S; Thrasher AJ; Baum C; Brenner S; Grez M
    Gene Ther; 2009 Jan; 16(1):111-8. PubMed ID: 18784749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lineage- and stage-restricted lentiviral vectors for the gene therapy of chronic granulomatous disease.
    Barde I; Laurenti E; Verp S; Wiznerowicz M; Offner S; Viornery A; Galy A; Trumpp A; Trono D
    Gene Ther; 2011 Nov; 18(11):1087-97. PubMed ID: 21544095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expansion of genetically corrected neutrophils in chronic granulomatous disease mice by cotransferring a therapeutic gene and a selective amplifier gene.
    Hara T; Kume A; Hanazono Y; Mizukami H; Okada T; Tsurumi H; Moriwaki H; Ueda Y; Hasegawa M; Ozawa K
    Gene Ther; 2004 Sep; 11(18):1370-7. PubMed ID: 15229634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lentiviral gene therapy for X-linked chronic granulomatous disease.
    Kohn DB; Booth C; Kang EM; Pai SY; Shaw KL; Santilli G; Armant M; Buckland KF; Choi U; De Ravin SS; Dorsey MJ; Kuo CY; Leon-Rico D; Rivat C; Izotova N; Gilmour K; Snell K; Dip JX; Darwish J; Morris EC; Terrazas D; Wang LD; Bauser CA; Paprotka T; Kuhns DB; Gregg J; Raymond HE; Everett JK; Honnet G; Biasco L; Newburger PE; Bushman FD; Grez M; Gaspar HB; Williams DA; Malech HL; Galy A; Thrasher AJ;
    Nat Med; 2020 Feb; 26(2):200-206. PubMed ID: 31988463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stable long-term gene correction with low-dose radiation conditioning in murine X-linked chronic granulomatous disease.
    Goebel WS; Pech NK; Dinauer MC
    Blood Cells Mol Dis; 2004; 33(3):365-71. PubMed ID: 15528159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromosome Transplantation: Correction of the Chronic Granulomatous Disease Defect in Mouse Induced Pluripotent Stem Cells.
    Castelli A; Susani L; Menale C; Muggeo S; Caldana E; Strina D; Cassani B; Recordati C; Scanziani E; Ficara F; Villa A; Vezzoni P; Paulis M
    Stem Cells; 2019 Jul; 37(7):876-887. PubMed ID: 30895693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-Clinical Efficacy and Safety Studies on G1XCGD, a Lentiviral Vector for Ex Vivo Gene Therapy of X-Linked Chronic Granulomatous Disease.
    Brendel C; Rothe M; Santilli G; Charrier S; Stein S; Kunkel H; Abriss D; Müller-Kuller U; Gaspar B; Modlich U; Galy A; Schambach A; Thrasher AJ; Grez M
    Hum Gene Ther Clin Dev; 2018 Jun; 29(2):69-79. PubMed ID: 29664709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene therapy of chronic granulomatous disease (CGD) by gene transfer into hematopoietic stem cells.
    Zentilin L; Tafuro S; Serra C; Falaschi A; Giacca M
    Ann Ist Super Sanita; 1998; 34(4):447-55. PubMed ID: 10234875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenovirus-mediated gene transfer into monocyte-derived macrophages of patients with X-linked chronic granulomatous disease: ex vivo correction of deficient respiratory burst.
    Schneider SD; Rusconi S; Seger RA; Hossle JP
    Gene Ther; 1997 Jun; 4(6):524-32. PubMed ID: 9231068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progress in gene therapy for chronic granulomatous disease.
    Malech HL
    J Infect Dis; 1999 Mar; 179 Suppl 2():S318-25. PubMed ID: 10081502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-selected co-expression of P-glycoprotein and gp91 in vivo from an MDR1-bicistronic retrovirus vector Ha-MDR-IRES-gp91.
    Sugimoto Y; Tsukahara S; Sato S; Suzuki M; Nunoi H; Malech HL; Gottesman MM; Tsuruo T
    J Gene Med; 2003 May; 5(5):366-76. PubMed ID: 12731085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A ubiquitous chromatin opening element prevents transgene silencing in pluripotent stem cells and their differentiated progeny.
    Pfaff N; Lachmann N; Ackermann M; Kohlscheen S; Brendel C; Maetzig T; Niemann H; Antoniou MN; Grez M; Schambach A; Cantz T; Moritz T
    Stem Cells; 2013 Mar; 31(3):488-99. PubMed ID: 23307570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene therapy for chronic granulomatous disease.
    Kume A; Dinauer MC
    J Lab Clin Med; 2000 Feb; 135(2):122-8. PubMed ID: 10695656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.